Related Experiment Video
Updated: May 13, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Symptom manageability in Swiss HIV-infected patients
Katharina Fierz1, Sandra Engberg, Dunja Nicca
1Institute of Nursing Science, University of Basel, Basel, Switzerland. katharina.fierz@unibas.ch
Background:
Managing symptoms in daily life is a challenging problem for people living with HIV. As traditional parameters used to identify symptoms needing management do not integrate aspects of daily living with symptoms, we introduced 'perceived symptom manageability' to fill this gap.
Aim:
The aim of this study was to quantitatively explore 'perceived symptom manageability' in a sample of 268 persons living with HIV.
Methods:
Secondary analysis of existing cross-sectional data. Social support, gender, age, depressive and anxiety symptoms were bivariately and multivariately analyzed and related to symptom experience and manageability as measured by the HIV Symptom Assessment Scale and the HIV Symptom Manageability Scale.
Results:
Least manageable symptoms were hair loss, vomiting and insomnia. Multivariately, age (beta=-.11; p=.024), symptom distress (beta=-.62; p<.001) and total anxiety and depressive symptoms (beta=-.18; p=.003) were statistically significant correlates of symptom manageability.
Conclusions:
Although a promising concept to identify symptoms needing management, further research employing primary data is recommended.
Related Concept Videos
Sexually Transmitted Infections
Retrovirus Life Cycles
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Nephrotic Syndrome II : Assessment and Medical Management
Rheumatic Heart Disease III: Medical Management
Therapeutic Drug Monitoring: Affecting Factors

